Low-grade chronic inflammation, characterized by elevated plasma concentrations of C-reactive protein (CRP), is associated with an increased risk of atherosclerotic cardiovascular disease. Endothelial cell activation is an early event in atherogenesis, and previous studies have reported correlations between indirect markers of endothelial cell activation and CRP concentration. Therefore, in the present study, we measured CRP concentration (and leptin concentration as an index of fat mass) in nine healthy subjects (mean age 53p8.1 years ; body mass index 27p3.2 kg/m 2 ; mean arterial blood pressure 101p9.0 mmHg) undergoing measurement of basal endothelial nitric oxide (NO) synthesis using intra-brachial infusions of N G -monomethyl-Larginine (L-NMMA ; a substrate inhibitor of endothelial NO synthase) and noradrenaline (a nonspecific control vasoconstrictor). In univariate analysis, CRP concentration was correlated with (i) the percentage decrease in forearm blood flow (FBF) during L-NMMA infusion (r l 0.85, P l 0.004) ; and (ii) the serum leptin concentration (r l 0.65, P l 0.05). In multivariate analysis, the relationship between CRP concentration and the FBF response to L-NMMA remained significant when age and leptin (t l 2.65, P l 0.045), age and BMI (t l 3.69, P l 0.014), or age and lowdensity-lipoprotein-cholesterol plus high-density-lipoprotein-cholesterol (t l 3.37, P l 0.044), were included in regression models. In contrast, the response of FBF to noradrenaline was not significantly related to CRP concentration. These data demonstrate for the first time a relationship between low-grade chronic inflammation and basal endothelial NO synthesis (measured using an invasive method), and support the notion that endothelial dysfunction is a critical intermediate phenotype in the relationship between inflammation and cardiovascular disease.
INTRODUCTION
There is increasing evidence to suggest a role for inflammation in the pathogenesis of cardiovascular disease. Low-grade chronic inflammation, demonstrated by persistent moderately elevated concentrations of C-reactive protein (CRP) within the normal range, has been shown to be predictive of both myocardial infarction and ischaemic stroke in prospective studies [1] . The same phenomenon is observed whether individuals studied are apparently healthy (with or without classical cardiovascular risk factors) or have established vascular disease [2, 3] . Moreover, it appears that a major component of event decrease due to HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors and aspirin may be attributable to their anti-inflammatory properties [4, 5] .
Inflammation may increase cardiovascular risk via effects on known cardiovascular risk factors (e.g. lipid profiles), by altering other putative risk markers (e.g. fibrinogen, plasminogen activator inhibitor-1), or by impairing carbohydrate metabolism [2] . Vascular endothelial dysfunction (as an early and critical step in atherogenesis) is an attractive alternative candidate mechanism, but there are few data on the effect of inflammation on endothelial function. On the basis of studies [6, 7] in which endotoxin or cytokines were instilled into temporarily isolated human dorsal hand veins in vivo, Vallance et al. [8] have proposed that acute infection or inflammation may result in a reversible decrease in endothelium-dependent vascular relaxation. More recently, there have been independent reports of correlations between CRP concentration and indirect plasma markers of endothelial cell activation [von Willebrand factor ; vascular cell-adhesion molecule (VCAM)-1] [9, 10] .
To date, measurement of CRP concentrations using a sensitive assay has not been reported in a group of subjects who have undergone a direct assessment of endothelial function. Therefore, in the present invasive clinical study, we tested the hypothesis that CRP concentration relates inversely to basal endothelial nitric oxide (NO) synthesis [measured using an intra-brachial infusion of N G -monomethyl-L-arginine (L-NMMA), the substrate inhibitor of endothelial NO synthesis] in a group of healthy middle-aged men. To examine the independence of any relationship between CRP and vascular reactivity, fasting lipids and leptin (as a biochemical marker of fat mass) were also measured and related to forearm blood flow (FBF) responses to L-NMMA. Finally, to examine the possibility of a nonspecific relationship between CRP and vascular reactivity, we used noradrenaline as a ' control ' vasoconstrictor.
METHODS
Nine healthy male subjects [mean age 53p8.1 years ; body mass index (BMI) 27p3.2 kg\m# ; mean arterial blood pressure 101p9.0 mmHg] were recruited. Only one was a cigarette smoker, and at study entry none of the men had symptoms or signs of overt cardiovascular disease or clinical evidence of recent or ongoing infection. No subject was taking any intercurrent drug treatment. The study was approved by the local ethical committee, and informed consent was obtained from each subject.
Studies were performed after an overnight fast, and subjects abstained from alcohol and caffeine-containing drinks for at least 12 h before study. A fasting venous blood sample was taken for determination of CRP, lipid, glucose and leptin concentrations. The CRP concentration was measured using an ultrasensitive doubleantibody sandwich ELISA (linear up to 5 mg\l and logarithmic thereafter). The inter-assay coefficient of variation was less than 10 % across the range of measured results. Glucose was measured using an automated enzymic method, and lipids [total cholesterol, triacylglycerol, low-density lipoprotein (LDL)-cholesterol and high-density lipoprotein (HDL)-cholesterol] were measured according to the protocols of the Lipid Research Clinics [11] . Plasma leptin concentrations were measured in duplicate using solid-phase "#&I-radioimmunoassays (Linco Research, St. Charles, MO, U.S.A.), and samples for quality control were included in each assay. The intra-and inter-assay coefficients of variation for the assay were 5.8 % and 6.5 % respectively over the sample concentration range.
Blood pressure was measured in triplicate after 10 min of supine rest by an oscillometric method using a Dinamap Critikon semi-automated sphygmanometer ( Johnson and Johnson Professional Products Ltd), maintained and calibrated at regular intervals by the Clinical Physics Department of the Western Infirmary, Glasgow.
FBF was measured in each subject by bilateral venous occlusion strain gauge plethysmography, as described previously [12] . In brief, a 27-G steel needle was inserted in the brachial artery of the non-dominant arm under local anaesthetic. Blood flow was recorded in both forearms during 3 min periods of wrist cuff occlusion at 8 min intervals ; each measurement was the mean of five sequential recordings. After an acclimatization period of 30 min, baseline measurements were recorded. Subjects then received an intra-arterial infusion of noradrenaline (50 ng\min) for 24 min ; this was followed by a 16 min washout period, recording of further baseline measurements and a subsequent infusion of L-NMMA (substrate inhibitor of NO synthase) at a dose of 1 mg\min for 24 min. The final (steady-state) measurement for each infusate was used in analysis. All results were expressed as the percentage change in the FBF ratio between the infused and non-infused (control) arms.
Statistics
Skewed data (CRP concentration) were logarithmically transformed. Relationships between continuous variables (age, BMI, fasting glucose, mean arterial pressure, lipids, leptin, noradrenaline and L-NMMA responses, and log [CRP]) were initially examined using simple linear correlation (Pearson's correlation coefficient). Multiple linear regression was then employed to examine the joint influence of age and obesity (serum leptin concentration or BMI) or age and lipids (LDL-cholesterol and HDL- 
RESULTS
The characteristics of the subjects studied are given in Table 1 . Of all baseline parameters measured, only log [CRP] correlated significantly with the response to L-NMMA (r l 0.85, P l 0.004 ; Figure 1 ). CRP concen- tration correlated significantly with serum leptin concentration (r l 0.65, P l 0.05). The relationship between CRP and response to L-NMMA persisted when age and leptin concentration (t l 2.65 ; P l 0.045 ; Table 2 ), or age and BMI (t l 3.69, P l 0.014), or age and LDLcholesterol plus HDL-cholesterol concentration (t l 3.37, P l 0.044), were included in regression models. The relationship also persisted when the cigarette smoker was excluded from the analysis. In contrast, there was a nonsignificant and inverse correlation between log [CRP] and noradrenaline response.
DISCUSSION
In this clinical study we provide, to the best of our knowledge, the first direct evidence for an association between endothelial dysfunction and low-grade chronic inflammation. Although we had only a small number of subjects, the range of both CRP concentrations and responses to L-NMMA was relatively large (Figure 1) . We observed that, as CRP concentration increased across the ' normal ' range, basal NO generation decreased significantly. In contrast, there was no significant relationship between CRP and the response to noradrenaline. Our data extend recent observations made by other investigators. Schalkwijk et al. [9] noted a correlation between circulating markers of endothelial activation (von Willebrand factor and vascular cell-adhesion molecule-1) and CRP concentration in patients with type I diabetes mellitus. In addition, Yudkin et al. [10] have reported a correlation between a different panel of endothelial activators (von Willebrand factor and cellular fibronectin) and CRP in non-diabetic subjects. Both groups have interpreted their results as suggesting a link between low-grade chronic inflammation and endothelial dysfunction.
Our data also complement previous experiments by Bhagat et al. [6, 7] , who noted that infusion of endotoxin or pro-inflammatory cytokines [interleukin-1, tumour necrosis factor-α (TNF-α)] into superficial hand veins of healthy volunteers (provoking a local acute inflammatory response) caused a selective impairment of endotheliumdependent relaxation. Their interpretation that such effects were related to inflammation was further strengthened by the observation that the impairment was abolished by prior oral treatment with cortisol or highdose aspirin [6] .
Plasma leptin concentrations were measured in the present study as a biochemical marker of fat mass [13] , and also correlated with CRP concentrations. This observation is consistent with recent evidence indicating a significant role for abdominal adipocytes in contributing to low-grade chronic inflammation through production of pro-inflammatory cytokines such as TNF-α and interleukin-6 [14] . Adiposity has been consistently linked also with endothelial dysfunction [10, 15, 16] . However, leptin concentrations did not correlate with the decrease in FBF during L-NMMA infusion, and the association between CRP and the response to L-NMMA did not appear to be confounded by age or leptin concentration, or by BMI.
Correlation does not imply causality, but the relationship we have suggested between inflammation and endothelial dysfunction is biologically plausible. Lowgrade chronic vascular inflammation may promote biochemical (e.g. peroxidative) and cellular changes in the vessel wall. In addition, TNF-α has been shown to reduce the half-life of mRNA encoding endothelial NO synthase [17] . A decrease in basal NO production secondary to low-grade chronic inflammation would favour increased expression of cell-surface adhesion molecules for leucocytes and platelets, promote interaction between these cells and the vascular endothelium, and induce procoagulant activity. Such effects, in turn, might increase the likelihood of vasospasm, thrombosis and vessel occlusion [1] . Thus endothelial dysfunction may be a critical factor in the relationship between low-grade chronic inflammation and cardiovascular disease.
In conclusion, we have shown for the first time a relationship between low-grade chronic inflammation and a direct measure of endothelial function. Our preliminary observations support the notion that endothelial dysfunction may be a critical intermediate phenotype in the relationship between low-grade chronic inflammation and cardiovascular disease. Clearly, larger clinical studies are now needed to expand upon our novel observations.
